On Jan 27, 2022 Enable Injections closed a Series C round and raised $215,000,000 from Cincinnati Children’s, CincyTech, Cintrifuse, GCM Grosvenor, Magnetar Capital, Ohio Innovation […]
Series A – TenSixteen Bio
On Jan 27, 2022 TenSixteen Bio closed a Series A round and raised $40,000,000 from Foresite Capital, GV, featuring lead investors Foresite Capital, GV. About […]
Series C – Eucalyptus
On Jan 27, 2022 Eucalyptus closed a Series C round and raised A$60,000,000 from AirTree Ventures, Athletic Ventures, Blackbird Ventures, Bond, NewView Capital, OneVentures, W23, […]
Funding Round – Naava
On Jan 27, 2022 Naava closed a Funding Round round and raised €7,000,000 from Butterfly Ventures, Mika Ihamuotila, Mikael Hed, Nidoco, Tesi, featuring lead investors […]
Post-IPO Equity – Salona Global
On Jan 27, 2022 Salona Global closed a Post-IPO Equity round and raised $4,004,000 from investors, featuring lead investors . About the company: Salona Global […]
Post-IPO Equity – Vaccinex
On Jan 27, 2022 Vaccinex closed a Post-IPO Equity round and raised $6,600,000 from Albert Friedberg, Jacob Frieberg, Maurice Zauderer, featuring lead investors . About […]
Grant – ALK Positive
On Jan 27, 2022 ALK Positive closed a Grant round and raised $1,500,000 from Lungevity Foundation, featuring lead investors Lungevity Foundation. About the company: ALK […]
Series C – Enable Injections
On Jan 27, 2022 Enable Injections closed a Series C round and raised $215,000,000 from Cincinnati Children’s, CincyTech, Cintrifuse, GCM Grosvenor, Magnetar Capital, Ohio Innovation […]
Series A – Ractigen Therapeutics
On Jan 27, 2022 Ractigen Therapeutics closed a Series A round and raised $30,000,000 from China Singapore Suzhou Industrial Park Ventures, Eisai, LC Ventures, SDIC […]
Series A – TenSixteen Bio
On Jan 27, 2022 TenSixteen Bio closed a Series A round and raised $40,000,000 from Foresite Capital, GV, featuring lead investors Foresite Capital, GV. About […]
